PHARMACIE ELSEN
ActiveSummary
PHARMACIE ELSEN has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €144k and a net result of €15k. Equity is growing by ~34.4% per year across the filed fiscal years. Its solvency ranks better than 33% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
53
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability51▼-26
Solvency48▲+2
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.24 against 1.28 in 2024; short-term debt: 75.6% and cash: 8.9% of total assets), and 77.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
22.7%
Return on assets
2.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
23 d early
2024
24 d early
2023
26 d late
2022
29 d late
2021
24 d late
2020
27 d late
2019
215 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€15k▼ 64.7%
2024 · €42k
2018: €20k
2020: €-18k
2021: €34k
2022: €8k
2023: €24k
2024: €42k
2018 → 2025
Working capital
€115k▼ 6.6%
2024 · €123k
2018: €39k
2020: €38k
2021: €66k
2022: €55k
2023: €62k
2024: €123k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€56k-€64k▲ 15.2%€88k▲ 37.0%€130k▲ 47.8%€144k▲ 11.4%
Operating result€45k-€15k▼ 65.6%€41k▲ 166%€69k▲ 68.2%€30k▼ 56.2%
Net result€34k-€8k▼ 75.2%€24k▲ 181%€42k▲ 76.9%€15k▼ 64.7%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 56% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €637k
Fixed assets
€40k ▼ 15.8%
Current assets
€597k ▲ 6.3%
Equity and liabilities €637k
Equity
€144k ▲ 11.4%
Debt
€493k ▲ 2.7%
Debt's share of the balance-sheet total falls from 78.7% to 77.3%. Equity and debt are higher.
Key figures and ratios
EBITDA
€38k▼
2024 · €77k
Cash flow
€22k▼
2024 · €49k
Current ratio
1.24▼
2024 · 1.28
Quick ratio
1.00▼
2024 · 1.07
Debt to equity
3.41▼
2024 · 3.70
ROE
10.2%▼
2024 · 32.3%
ROA
2.3%▼
2024 · 6.9%
Interest coverage
3.58▼
2024 · 6.10
Debt ≤ 1 year
€482k▲
2024 · €438k
Debt > 1 year
€8k▼
2024 · €37k
Income taxes
€5k▼
2024 · €15k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet
Code20242025
Assets
Total assets20/58€609k€637k▲
Fixed assets21/28€48k€40k▼
Tangible fixed assets22/27€48k€40k▼
Plant, machinery and equipment23€383€245▼
Furniture and vehicles24€4k€2k▼
Other tangible fixed assets26€43k€38k▼
Current assets29/58€561k€597k▲
Stocks and contracts in progress3€91k€113k▲
Stocks30/36€91k€113k▲
Amounts receivable within one year40/41€372k€423k▲
Trade receivables40€149k€168k▲
Other amounts receivable41€223k€255k▲
Cash at bank and in hand54/58€93k€57k▼
Deferred charges and accrued income490/1€5k€4k▼
Equity and liabilities
Total equity and liabilities10/49€609k€637k▲
Equity10/15€130k€144k▲
Contributions10/11€50k€50k=
Profit (loss) carried forward14€80k€94k▲
Amounts payable17/49€479k€493k▲
Amounts payable after more than one year17€37k€8k▼
Financial debts170/4€37k€8k▼
Amounts payable within one year42/48€438k€482k▲
Current portion of amounts payable after more than one year42€35k€33k▼
Financial debts43€125k€125k=
Credit institutions430/8€125k€125k=
Trade debts44€238k€293k▲
Suppliers440/4€238k€293k▲
Taxes, remuneration and social security45€10k€9k▼
Taxes450/3€10k€9k▼
Other amounts payable47/48€31k€22k▼
Accrued charges and deferred income492/3€5k€3k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7k€8k▲
Other operating charges640/8€548€558▲
Gross operating margin9900€77k€38k▼
Operating profit (loss)9901€69k€30k▼
Financial income75/76B€99€94▼
Recurring financial income75€99€94▼
Financial charges65/66B€13k€11k▼
Recurring financial charges65€13k€11k▼
Profit (loss) for the period before taxes9903€57k€20k▼
Income taxes67/77€15k€5k▼
Profit (loss) for the period9904€42k€15k▼
Profit (loss) for the period to be appropriated9905€42k€15k▼
Appropriation of the result
Profit (loss) to be appropriated9906€80k€94k▲
Profit (loss) brought forward from the previous period14P€38k€80k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
08-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
07-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Highest result since 2018net €42k ▲76.9%
Operating result €69k, net result €42k, both a record.
31-12
Financial
Equity above €100kEq €130k ▲47.8%
4 profitable years in a row build equity to €130k.
26-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 26 days late
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 29 days late
2022
24-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 24 days late
2021
31-12
Financial
Back to profitnet €34k
Net result €34k after one loss-making year.
27-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 27 days late
03-03
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 215 days late
2020
31-12
Financial
Weakest financial yearnet €-18k ▼187%
Net result drops to €-18k, the lowest in the series; recovery starts the following year.
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 27 days late
2018
27-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 27 days late
2017
27-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beauraing · 1 establishment unit since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
rue de l'Aubépine 955570 BeauraingGround area
1,378 m²
Building footprint
567 m²
Volume, LiDAR
1,333 m³
2 parcels, Wallonia · tallest building 12.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
PHARMACIE ELSEN
since 20042.145.319.603
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 91013A1269/00R000 | Wallonia | 1,030 m² | 1 · 428 m² | - |
| 91141B0027/00R000 | Wallonia | 349 m² | 1 · 139 m² | 12.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteYvoir2.145.319.603
Similar companies · same sector, comparable size
Apotheek Kinget Schiplaken
BE 0810.143.109
Boortmeerbeek · Eq €144,438
PHARMACIE DAVOINE
BE 0444.488.642
Vorst · Eq €144,505
Pharmacie Deffense Van Elslande
BE 0471.525.809
Rixensart · Eq €144,294
AS PHARMA
BE 0792.238.986
Charleroi · Eq €144,219
APOTHEEK PORTUENSIS
BE 0866.696.582
Dendermonde · Eq €144,638
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,564 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-09-2004
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.